Hydrolysis of glucosylceramide by beta-glucocerebrosidase results in ceramide, a critical component of the intercellular lamellae that mediate the epidermal permeability barrier. A subset of type 2 Gaucher patients displays ichthyosiform skin abnormalities, as do transgenic Gaucher mice homozygous for a null allele. To investigate the relationship between glucocerebrosidase deficiency and epidermal permeability barrier function, we compared the stratum corneum (SC) ultrastructure, lipid content, and barrier function of Gaucher mice to carrier and normal mice, and to hairless mice treated topically with bromoconduritol B epoxide (BrCBE), an irreversible inhibitor of glucocerebrosidase. Both Gaucher mice and BrCBE-treated mice revealed abnormal, incompletely processed, lamellar body-derived sheets throughout the SC interstices, while transgenic carrier mice displayed normal bilayers. The SC of a severely affected type 2 Gaucher's disease infant revealed similarly abnormal ultrastructure. Furthermore, the Gaucher mice demonstrated markedly elevated transepidermal water loss (4.2 +/- 0.6 vs < 0.10 g/m2 per h). The electron-dense tracer, colloidal lanthanum, percolated between the incompletely processed lamellar body-derived sheets in the SC interstices of Gaucher mice only, demonstrating altered permeability barrier function. Gaucher and BrCBE-treated mice showed < 1% and < 5% of normal epidermal glucocerebrosidase activity, respectively, and the epidermis/SC of Gaucher mice demonstrated elevated glucosylceramide (5- to 10-fold), with diminished ceramide content. Thus, the skin changes observed in Gaucher mice and infants may result from the formation of incompetent intercellular lamellar bilayers due to a decreased hydrolysis of glucosylceramide to ceramide. Glucocerebrosidase therefore appears necessary for the generation of membranes of sufficient functional competence for epidermal barrier function.
W M Holleran, E I Ginns, G K Menon, J U Grundmann, M Fartasch, C E McKinney, P M Elias, E Sidransky
Title and authors | Publication | Year |
---|---|---|
Effective cell and gene therapy in a murine model of Gaucher disease
IB Enquist, E Nilsson, A Ooka, JE Månsson, K Olsson, M Ehinger, RO Brady, J Richter, S Karlsson |
Proceedings of the National Academy of Sciences | 2006 |
Glucosylceramide transfer from lysosomes—the missing link in molecular pathology of glucosylceramidase deficiency: A hypothesis based on existing data
M Elleder |
Journal of Inherited Metabolic Disease | 2006 |
Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3
CG Strong, PW Wertz, C Wang, F Yang, PS Meltzer, T Andl, SE Millar, IC Ho, SY Pai, JA Segre |
The Journal of Cell Biology | 2006 |
Barrier Dysfunction and Pathogenesis of Neutral Lipid Storage Disease with Ichthyosis (Chanarin–Dorfman Syndrome)
M Demerjian, DA Crumrine, LM Milstone, ML Williams, PM Elias |
Journal of Investigative Dermatology | 2006 |
Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease
WM Holleran, SG Ziegler, O Goker-Alpan, MJ Eblan, PM Elias, R Schiffmann, E Sidransky |
Clinical Genetics | 2006 |
Epidermal sphingolipids: Metabolism, function, and roles in skin disorders
WM Holleran, Y Takagi, Y Uchida |
FEBS Letters | 2006 |
The skin barrier in healthy and diseased state
JA Bouwstra, M Ponec |
Biochimica et Biophysica Acta (BBA) - Biomembranes | 2006 |
Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3
CG Strong, PW Wertz, C Wang, F Yang, PS Meltzer, T Andl, SE Millar, IC Ho, SY Pai, JA Segre |
The Journal of Cell Biology | 2006 |
Integrity and Barrier Function of the Epidermis Critically Depend on Glucosylceramide Synthesis
R Jennemann, R Sandhoff, L Langbein, S Kaden, U Rothermel, H Gallala, K Sandhoff, H Wiegandt, HJ Gröne |
The Journal of biological chemistry | 2006 |